News Release
<< Back
New Vaprisol Study Supports A Reduced Dose In Patients With Severe Liver Impairment
New Vaprisol Study Supports A Reduced Dose In Patients With Severe Liver Impairment
-
Investor Relations
-
Contact Us
Corporate Headquarters
Cumberland Pharmaceuticals Inc.
2525 West End Avenue, Suite 950
Nashville, Tennessee 37203Phone: (615) 255-0068
Toll Free: (877) 484-2700
Fax: (615) 255-0094*For directions to us, please see Location
Employment Opportunities
employment@cumberlandpharma.com
Investor Relations
investors@cumberlandpharma.com
Business Development
development@cumberlandpharma.com
Wholesaler Customer Service
Phone: (877) 274-7200
Fax: (614) 652-9127Medical Information
This website is not for medical emergencies. If you are a patient, caregiver or healthcare professional and need product related information, please visit our Products page, which will link you to product-specific websites.
Adverse Event Reporting
Toll Free Phone: (866) 767-5077
(For healthcare professionals only)